Free Trial

The Biotech Growth Trust (LON:BIOG) Share Price Passes Below Fifty Day Moving Average - Here's What Happened

The Biotech Growth Trust logo with Financial Services background

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 823.62 ($10.62) and traded as low as GBX 726 ($9.36). The Biotech Growth Trust shares last traded at GBX 754 ($9.72), with a volume of 503,509 shares changing hands.

The Biotech Growth Trust Price Performance

The company has a market cap of £195.98 million, a price-to-earnings ratio of 2.30 and a beta of 0.50. The company has a current ratio of 0.59, a quick ratio of 0.00 and a debt-to-equity ratio of 11.02. The business has a 50-day moving average price of GBX 812.76 and a 200 day moving average price of GBX 902.25.

Insider Activity

In other news, insider Nicola Shepherd acquired 1,000 shares of the firm's stock in a transaction that occurred on Monday, January 13th. The stock was purchased at an average price of GBX 846 ($10.91) per share, with a total value of £8,460 ($10,909.09). 0.71% of the stock is currently owned by company insiders.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

See Also

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines